Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AHIP, Biomedical, blinded, Branch, built, cashflow, Charlotte, CI, Concord, congenital, conservationist, Coventry, Cth, CTN, died, element, empowered, excessive, FATA, Fiona, FIRB, Fortune, Forum, grew, hypoplastic, ICR, Joe, JV, King, Langone, Loyola, LV, merit, microvascular, musculoskeletal, NYU, ODD, paediatric, persistently, PhD, philanthropist, Pillar, quadrupled, readout, RehabCare, resilience, Restated, row, RPD, RPDD, Rulebook, sacrifice, stack, strongly, subscribed, Thoracic, today, TR, underwater, underwent, undetected, vi, Virginia
Removed:
AbbVie, Abeona, abnormal, academia, accumulate, blockbuster, bridge, Bristol, building, busy, Celgene, Cincinnati, Clementia, Cline, CNS, comparator, congressional, continuity, corrected, covid, Diplomat, DSMB, Eli, emergency, enrolment, FAPA, Fellow, floating, Fred, Gamble, Gamida, GI, Gilead, Glenmark, Grossman, Grossmann, halted, infection, ingredient, Ipsen, Josh, Kite, LFSP, Lilly, lung, migrate, mismanagement, Muntner, Murray, NeuroRx, OTAT, Pfizer, Pharma, powered, preserving, Principia, Procter, Psychiatric, psychiatrist, recruited, refinance, refinanced, reject, respiratory, SA, Sanofi, Shawn, shortening, sober, Southern, Specialty, Squibb, Sunovion, survival, tame, TCR, Tomasello, tract, transactional, urogen, ventilation, ventilator, vigorously, virology, weighting
Filing tables
Filing exhibits
MESO similar filings
Filing view
External links
Exhibit 13.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Mesoblast Limited (the “Company”) on Form 20-F for the year ended June 30, 2024 as filed on the date hereof (the “Report”), I, Andrew Chaponnel, Interim Chief Financial Officer for the Company, certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
I, Andrew Chaponnel, certify that:
1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 29, 2024 | By: | /s/ Andrew Chaponnel | ||||||
Andrew Chaponnel | ||||||||
Interim Chief Financial Officer |